Search

Headquarters

Contact Us

  • (+01) 512 835 8026
  • info@myriadrbm.com
  • 3300 Duval Road
    Austin, TX 78759
    USA
  • Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started

  • (+01) 512 835 8026
  • info@myriadrbm.com
Get a Quote | Contact | FAQ's | Blog
Myriad RBM Myriad RBM

Innovative Biomarker Solutions

Toggle menu

Skip to content
  • About Us

    • About Myriad RBM

      Myriad RBM’s CLIA certified biomarker testing laboratory, is located in Austin, TX. Myriad RBM is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN), a leading molecular diagnostic company based in Salt Lake City, Utah which develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests.

    • About Myriad RBM

      • Overview
      • Management
      • Quality Policy
      • Employment
      • Partners
      • Sales Team
      • Certifications

    • Newsroom

      • Press
      • Company Newsletters
      • Conferences
      • Abstracts + Papers
      • Sign Up for Our Newsletter
      • Blog

    • Data Quality

      • Overview
      • Myriad RBM Technology
  • Biomarker Solutions

    • Solutions

      • Overview
      • Assay Change Log

      CustomMAP

      If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.

      Build Your CustomMAP »

    • Multiplexed Immunoassays

      • Full Biomarker Menu
      • DiscoveryMAP® v. 3.3
      • ExplorerMAP™ v. 1.0
      • HumanMAP® v. 2.0
      • CardiovascularMAP® v. 3.0
      • AngiogenesisMAP® v. 1.0
      • InflammationMAP® v. 1.0
      • ImmunoMAP® v. 1.0
      • NeuroMAP™ v. 1.0
      • MetabolicMAP® v. 1.0
      • KidneyMAP®
      • CytokineMAP A
      • CytokineMAP B
    • TruCulture

      Whole Blood Collection and Culture System

      Learn More »
      Quanterix simoa

      Ultrasensitive immunoassays manufactured by Myriad RBM and based on Quanterix’s Simoa technology.

      Learn More »
      Vectra DA

      The only validated multibiomarker blood test to measure rheumatoid arthritis (RA) disease activity.

      Learn More »
  • Resources + Support

    • Resources

      • Bibliography
      • White Papers
      • Events
      • Webinars
      • Blog

    • Support

      • Client Services
      • Request a Biomarker
      • Speak to a Scientist
  • How to Order

    • Ordering Information

      • Overview
      • Request a quote
      • Acceptable Samples
      • Frequently Asked Questions

    • Request Information

      • Contact Client Services
      • Request a Biomarker
      • Speak to a Scientist

    • Ready to Order?

      Great!

      Every order starts with a quote.

      Get Started

  •  

Category Archives: Blog

16 Apr 2015

Prototypic modified risk tobacco product reduces cigarette smoke induced inflammation and COPD symptoms in mice

April 16, 2015
Desiree Klingler-Gaston
Inflammation
Researchers at Philip Morris used Myriad RBM’s RodentMAP (Multi-Analyte Profiling) immunoassay service and other histological and functional assessmen...
Read More
20 Feb 2015

Pharmacodynamic biomarkers for Apremilast treatment in psoriatic arthritis

February 20, 2015
myriadrbm
Blog, Cancer, Inflammation
A new paper from Peter Schafer, et al, of Celgene shows how biomarkers can be used to monitor treatment response in an inflammatory disease setting. T...
Read More
31 Oct 2014

ENRAGE: A Novel Inflammatory Marker for Incident Coronary Heart Disease

October 31, 2014
Desiree Klingler-Gaston
Cardiac, Inflammation, Utilized Myriad RBM's Services
This recent paper in the Arteriosclerosis, Thrombosis and Vascular Biology Journal of the American Heart Association describes an interesting prospect...
Read More
15 Sep 2014

Blood-based proteins are crucial to the development of biomarker tests aimed at improving the diagnosis and treatment of psychiatric disorders

September 15, 2014
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological, Utilized Myriad RBM's Services
A recent review of studies measuring proteins in blood serum/plasma illustrates the systemic nature of disease-related changes in patients with schizo...
Read More
29 Aug 2014

Biomarker signatures predict clinical outcomes in metastatic colorectal cancer (mCRC) patients treated with chemotherapy and cediranib

August 29, 2014
myriadrbm
Blog, Cancer, Utilized Myriad RBM's Services
Researchers sought to explore biomarkers in pre- and on- treatment mCRC patients receiving chemotherapy with and without cediranib, in order to identi...
Read More
21 Aug 2014

Vitamin D Binding Protein in serum demonstrates utility as a biomarker of Alzheimer’s disease

August 21, 2014
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological, Utilized Myriad RBM's Services
Researchers at the University of Texas Health Science Center, San Antonio used a Multiple Indicators Multiple Causes (MIMIC) approach to evaluate the...
Read More
13 Aug 2014

Blood-based proteins help elucidate mediators of cognitive impairment in Late Life Depression (LLD)

August 13, 2014
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological, Utilized Myriad RBM's Services
Researchers from the University of Pittsburgh analyzed 242 proteins in conjunction with structural brain abnormalities to identify biological mechanis...
Read More
1 … 4 5 6 7 8 … 19

Categories

  • Blog (129)
    • Autoimmune and Arthritis (10)
    • Cancer (28)
    • Cardiac (9)
    • Cytokines and Chemokines (21)
    • Diabetes (7)
    • Gastrointestinal (1)
    • Inflammation (42)
    • Neuroscience and Neurological (32)
    • News From the Lab (1)
    • Renal Function and Toxicity (8)
    • Technology- Multi-Analyte Profile (1)
  • Press (37)
  • Utilized Myriad RBM's Services (41)

ABOUT MYRIAD RBM

Overview
Management
Quality Policy
Employment
Partners
Sales Team
Certifications

NEWSLETTERS

Sign up to receive emails from Myriad RBM


MAPs

Full Biomarker Menu
DiscoveryMAP® v. 3.3
ExplorerMAP™ v. 1.0
HumanMAP® v. 2.0
CardiovascularMAP® v. 3.0
AngiogenesisMAP® v. 1.0
InflammationMAP® v. 1.0
ImmunoMAP® v. 1.0
NeuroMAP™ v. 1.0
MetabolicMAP® v. 1.0
KidneyMAP®
CytokineMAP A
CytokineMAP B

RESOURCES

Bibliography
White Papers
Events
Webinars
Blog

SUPPORT

Customer Support
Speak to a Scientist
Assay Change Log
FAQs
Request a Biomarker

SOLUTIONS

Results Processing
Assay Development
Quality Control
Project Management

SERVICES

Multiplexed Assay Services
Ultrasensitive Assays
TruCulture
VectraDA

  • Jobs
  • Terms of Use
  • Privacy Practice
  • Analytes Listing
Copyright © 2020 Myriad RBM. All rights reserved. Myriad does not sell your personal information